Methods -DRGN were prepared and cultured with or without the addition of sialidase (8 mU/ml) or the glycosphingolipid metabolic inhibitor P4 (2 μM) as described in the text. After 24 h a portion of the microwells were removed and the neurons fixed in 2% paraformaldehyde, then washed three times with PBS and kept at 4°C until use. After 48 h the remaining microwells were fixed in the same way. Groups of microwells (untreated, sialidase-treated and P4-treated) at 24 h and 48 h were immunostained with anti-ganglioside monoclonal antibodies (GT1b-2b or GM1-2b, see (1)) as follows. Wells were blocked with PBS containing 2% normal goat serum, washed with PBS, and primary antibodies (10 μg/ml in PBS/2% goat serum) were added. After 4 h at ambient temperature, the wells were washed three times with PBS and secondary antibody (Cy3-labelled goat anti-mouse IgG, Fc-specific, Jackson Immunoresearch, 4 μg/ml) were added. After 1 h at ambient temperature the wells were washed with PBS and fluorescent microscopic images obtained as described in the text.
-P4 and sialidase diminish GT1b ganglioside expression on cultured DRGN. Cells cultures in the absence (Control) or presence of P4 (2 μM) or sialidase (8 mU/ml) for 24 h were fixed and immunostained with IgG-class monoclonal antibodies (1) against GT1b or GM1 as indicated. Detection of antibody binding was via Cy3-fluoescent labeled secondary antibody. Fluorescent images were collected using the identical settings for each antibody, and are rendered in reversed grayscale for clarity.
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